Roche (RHHBY) recently announced that the US Food and Drug Administration (FDA) has approved Tarceva (erlotinib) tablets for the first line treatment of...(
read more)
Roche (RHHBY) recently announced that it has entered into a collaboration agreement with Ascletis to develop and commercialize Roche’s candidate danoprevir in China for treating patients...(
read more)
The following conversation took place between my wife and I a few months ago. Mrs. L: I really think you should get a flu shot this year. Me: I’ve never gotten one before and I’ve never come down with...(
read more)